Professional Documents
Culture Documents
Ansi Ashrae Standard 185.1-2020
Ansi Ashrae Standard 185.1-2020
This Standard is under continuous maintenance by a Standing Standard Project Committee (SSPC) for which the Standards
Committee has established a documented program for regular publication of addenda or revisions, including procedures for
timely, documented, consensus action on requests for change to any part of the Standard. Instructions for how to submit a
change can be found on the ASHRAE® website (https://www.ashrae.org/continuous-maintenance).
The latest edition of an ASHRAE Standard may be purchased from the ASHRAE website (www.ashrae.org) or from
ASHRAE Customer Service, 1791 Tullie Circle, NE, Atlanta, GA 30329-2305. E-mail: orders@ashrae.org. Fax: 678-539-
2129. Telephone: 404-636-8400 (worldwide), or toll free 1-800-527-4723 (for orders in US and Canada). For reprint per-
mission, go to www.ashrae.org/permissions.
* Denotes members of voting status when the document was approved for publication
SPECIAL NOTE
This American National Standard (ANS) is a national voluntary consensus Standard developed under the auspices of ASHRAE. Consensus is defined
by the American National Standards Institute (ANSI), of which ASHRAE is a member and which has approved this Standard as an ANS, as
“substantial agreement reached by directly and materially affected interest categories. This signifies the concurrence of more than a simple majority,
but not necessarily unanimity. Consensus requires that all views and objections be considered, and that an effort be made toward their resolution.”
Compliance with this Standard is voluntary until and unless a legal jurisdiction makes compliance mandatory through legislation.
ASHRAE obtains consensus through participation of its national and international members, associated societies, and public review.
ASHRAE Standards are prepared by a Project Committee appointed specifically for the purpose of writing the Standard. The Project
Committee Chair and Vice-Chair must be members of ASHRAE; while other committee members may or may not be ASHRAE members, all
must be technically qualified in the subject area of the Standard. Every effort is made to balance the concerned interests on all Project Committees.
The Senior Manager of Standards of ASHRAE should be contacted for
a. interpretation of the contents of this Standard,
b. participation in the next review of the Standard,
c. offering constructive criticism for improving the Standard, or
d. permission to reprint portions of the Standard.
DISCLAIMER
ASHRAE uses its best efforts to promulgate Standards and Guidelines for the benefit of the public in light of available information and accepted
industry practices. However, ASHRAE does not guarantee, certify, or assure the safety or performance of any products, components, or systems
tested, installed, or operated in accordance with ASHRAE’s Standards or Guidelines or that any tests conducted under its Standards or Guidelines
will be nonhazardous or free from risk.
CONTENTS
ANSI/ASHRAE Standard 185.1-2020
Method of Testing UV-C Lights for Use in Air-Handling Units or Air Ducts
to Inactivate Airborne Microorganisms
SECTION PAGE
Foreword ..................................................................................................................................................................... 2
1 Purpose............................................................................................................................................................. 2
2 Scope ................................................................................................................................................................ 2
3 Definitions ......................................................................................................................................................... 3
4 Test Apparatus and Procedures ....................................................................................................................... 3
5 Apparatus Qualification Testing ........................................................................................................................ 5
6 Bioaerosol Testing ............................................................................................................................................ 6
7 Determination of Performance .......................................................................................................................... 7
8 Reporting Results ............................................................................................................................................. 9
9 Normative References ..................................................................................................................................... 9
Informative Appendix A: Test Organism ............................................................................................................... 10
Informative Appendix B: Limitations ...................................................................................................................... 11
Informative Appendix C: Safety............................................................................................................................. 12
Informative Appendix D: Environmental Considerations ....................................................................................... 13
Informative Appendix E: Microorganism Susceptibility to UV-C Irradiation........................................................... 14
Informative Appendix F: Technical Issues Regarding Aerosol.............................................................................. 15
Informative Appendix G: Dosage Calculation........................................................................................................ 16
Informative Appendix H: Informative References.................................................................................................. 17
Informative Appendix I: Addenda Description and Information ............................................................................. 18
NOTE
Approved addenda, errata, or interpretations for this standard can be downloaded free of charge from the ASHRAE
website at www.ashrae.org/technology.
© 2020 ASHRAE
1791 Tullie Circle NE · Atlanta, GA 30329 · www.ashrae.org · All rights reserved.
ASHRAE is a registered trademark of the American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc.
ANSI is a registered trademark of the American National Standards Institute.
© ASHRAE. Provided to the public as part of ASHRAE'S COVID-19 response . Per international copyright law,
additional reproduction, distribution, or transmission in either print or digital form is not permitted without ASHRAE's prior written permission.
(This foreword is not part of this standard. It is merely informative and does not contain
requirements necessary for conformance to the standard. It has not been processed
according to the ANSI requirements for a standard and may contain material that has
not been subject to public review or a consensus process. Unresolved objectors on infor-
mative material are not offered the right to appeal at ASHRAE or ANSI.)
FOREWORD
Test standards form the foundation for air-cleaner selection in the ventilation industry. U.S.
Environmental Protection Agency (USEPA) literature states that the most important need in the
area of ultraviolet germicidal irradiation (UVGI) is industry standards to rate installed
devices. Standards for testing and reporting on products under controlled conditions are essen-
tial to users and specifiers so that they can compare products, predict levels of performance
under specified operating conditions with reasonable certainty, and determine appropriate
UVGI efficiencies for specific situations.
Historically, standards for testing air cleaners have been developed in response to the
needs of the day. Protection of machinery and coils came first, then reduction of soiling. Con-
cerns about indoor air quality and respirable particles, protection of products during manufac-
turing, and protection of HVAC equipment prompted development of test standards based on
particle size. In 2005, interest in controlling airborne infectious contaminants or viable species
that produce chemical contaminants as metabolic byproducts led to the formation of Standing
Standards Project Committee (SSPC) 185 to develop a method of test to determine inactivation
rates of airborne microorganisms in air-handling units and air ducts.
This is a test-method standard, and its results are to be used to directly compare UVGI
equipment on a standardized basis irrespective of their application. Results are also used to
give the design engineer an easy-to-use basis for specifying UV devices or estimating the rela-
tive performance of UVGI for a given application. It is possible that an industry organization
may use this test method as the basis for an application standard in which they might require
testing at conditions different than those required here. This test specifies two organisms for
testing but allows other organisms to be used as long as the test reports are correctly labeled.
The 2020 revision to Standard 185.1 reflects changes to the last version of the method to spec-
ify the airflow for the test as 3400 m3/h (2000 cfm), revisions to the QA section to make the tests
clearer, and significant revisions to the calculations to better reflect bioaerosol testing reality.
Informative notes are used throughout this standard to provide nonmandatory guidance for
the user in addition to the nonmandatory guidance found in informative appendices. Informa-
tive notes are not part of the standard.
This test method may also be used to test air-cleaning devices that do not use ultraviolet
technology, as long as the device being tested can be installed in the testing duct system
described in this method. Test reports should note that results were from a modified test and
include the specific device tested and modifications made to the method. Work is underway to
develop a bioaerosol test method that will allow more comprehensive testing of additional air-
cleaning devices.
1. PURPOSE
This standard establishes a test method for evaluating the efficacy of UV-C lights for their abil-
ity to inactivate airborne microorganisms.
2. SCOPE
2.1 This standard describes a method of laboratory testing to measure the performance of UV-C
lights used in general ventilating systems.
2.2 The method of test measures the performance of UV-C lights to inactivate selected indica-
tor microorganisms in the airstream. The standard defines procedures for generating the bio-
aerosols required for conducting the test. It also provides a method for counting the airborne
bioaerosols upstream and downstream of the UV-C light in order to calculate inactivation effi-
ciency for each microorganism.
2.3 This standard also establishes performance specifications for the equipment required to
conduct the tests, defines methods of calculating and reporting results obtained from the test
data, and establishes a reporting system to be applied to UV-C lights covered herein.
Figure 1 Test apparatus (a) side-view detail and (b) top-view detail.
4.1.5 The test apparatus shown in Figure 1 is designed for test devices with nominal face
dimensions of 610 × 610 mm (24 × 24 in.) and a length of 1 m (39.4 in.) before and 1 m
(39.4 in.) after the test section. A baffle on the upstream end of the reflective duct section
shall be flat black with less than 5% reflectivity and optional baffle on the downstream end of
the reflective duct section of the same reflectivity. A UV light baffle must be added 1 m (39.4
in.) upstream; a downstream UV light baffle is optional. If the postexposure sampling occurs
greater than 1 m (39.4 in.) downstream from the UV device, the downstream UV light baffle
is required. For purposes of this test, the duct walls for the section between the baffle and the
downstream sampling point must be constructed with a reflectivity of 50% to 60% (e.g., a
typical galvanized duct material). The reflectivity measurements of the duct wall shall be
included in the report. A radiometer measurement shall be made to determine the effective-
ness of the UV light baffle.
4.2 Installation of UV-C Device. Installation of the UV-C device, and configuration of the
lamp assembly within the device, shall be as designated by the manufacturer or equipment pro-
vider. The burn-in time for lamps shall be 100 hours 2.
4.3 Installation of Bioaerosol Sampler. At least one bioaerosol sampler shall be installed
upstream from the UV light after the first mixing baffle and before the upstream light baffle,
and one collection device shall be installed downstream from the UV light baffle and down-
stream from the second mixing baffle. The inlet of the bioaerosol sampler shall be located in
the middle of the airflow stream and shall face into the airflow. Isokinetic sampling (to within
10% of a measured target flow velocity as measured by the devices indicated) shall be main-
tained in the bioaerosol sampler. Flow rate through the sampling system shall be measured
with volumetric devices to within 5% (e.g., orifice plates and rotometers).
4.4 Mandatory and Discretionary Requirements. Critical dimensions and arrangements of
the test apparatus are shown in Figure 1. All dimensions shown are mandatory unless other-
wise indicated. Either SI or I-P dimensions are acceptable for any element of the system. Units
shown are in mm (in.) unless otherwise indicated. The design of equipment not specified,
including, but not limited to, blowers, valves, and external piping, is discretionary, but the
equipment must have adequate capacity to meet the requirements of this standard.
6. BIOAEROSOL TESTING
6.1 Bioaerosols
6.1.1 Test Organisms. The bioaerosol tests will be conducted using two organisms, cover-
ing the range of reasonable interest for UV-C device applications. The first organism to be used
in the test is Mycobacterium parafortuitum (ATCC® 19686), and the second organism is
Aspergillus sydowii (ATCC® 36542).
Informative Note: Mycobacterium parafortuitum is a nonmotile, rod-shaped bacterium 2
to 4 µm long (Wayne and Kubica 1986). It grows rapidly on standard bacterial culture media
and produces smooth, pale yellow colonies that disperse readily in water. Aspergillus sydowii
is 2 µm in diameter and is utilized as the surrogate for fungi. These test organisms have been
used in prior studies of UV-C radiation (Grinshpun et al. 2003; Kujundzic et al. 2007; VanOs-
dell and Foarde 2002; Xu et al. 2003, 2005).
6.1.2 Bioaerosol Preparation and Generation. Preparation of the test organism suspension
for the aerosolization requires that the test organism be grown in the laboratory and the suspen-
sion prepared for aerosol generation in the test duct. The microbial challenge suspensions are
prepared by inoculating the test organism onto solid or into liquid media, incubating the culture
until mature, harvesting organisms from the surface of the pure culture (if solid media), and
suspending them into sterile fluid to a known concentration to serve as a stock solution. The
organism preparation is then diluted into the nebulizing fluid for Collison preparation. The
nebulizing liquid shall be sterile deionized (DI) water. The nebulizing fluid is quantified on
agar plates to enumerate the number of test organisms in the suspension. The number of cultur-
able organisms shall be at least 106 CFU per mL.
The bioaerosol generation system shall provide a stable test bioaerosol of sufficient concen-
tration to allow measurement to show 99% inactivation. The generation system includes a six-
jet nebulizer that is based on air-atomizing spray nozzles in which a suspension of microorgan-
isms is nebulized with compressed air and then dried. The six-jet nebulizer generates droplets
with an approximate volume mean diameter of 2 µm. The particle diameter after the water evap-
orates depends on the solids content of the suspension. Particle size is determined by the size of
the suspended particles. The concentration in the Collison should be such that only singlets are
generated. The bioaerosol generator shall be designed to ensure that the microorganisms are dry
7. DETERMINATION OF PERFORMANCE
The primary measure of performance within this test method is the single-pass bioaerosol inac-
tivation efficiency. This efficiency shall be characterized in terms of the percentage of Asper-
gillus sydowii (ATCC® 36542) and Mycobacterium parafortuitum (ATCC® 19686) that could
not be cultured after UV-C radiation exposure 4,5,6,7. The single-pass bioaerosol inactivation
efficiency, UVGI, shall be quantified by comparing the bioaerosol concentration upstream and
downstream of the UV-C device using the following general equation:
C downstream
UVGI % = 1 – --------------------------
- 100% (1)
C upstream
where
Cdownstream = average culturable bioaerosol concentration measured in the test duct
downstream of the UV-C device, CFU/m3 (CFU/f3)
Cupstream = average culturable bioaerosol concentration measured in the test duct
upstream of the UV-C device, CFU/m3 (CFU/f3)
This general equation is corrected for system biases according to Section 7.1.
7.1 Correction for No-Light Transmission Rate. There is also a potential bias in the bio-
aerosol measurements if the test duct and rig cause a change in the number of culturable organ-
isms independent of the presence of a UV-C device. For this reason, a no-light transmission
rate (UV-C light is not turned on in the test duct) is measured and applied as an additional cor-
rection to the single-pass bioaerosol inactivation efficiency. The no-light transmission rate is
calculated by measuring the numbers of culturable organisms upstream and downstream with-
out the UV-C light turned on. The same sampling methods are used as in the single-pass bio-
aerosol inactivation efficiency test, but the calculation is performed using the opposite control
limit values to give the most conservative estimate. The equation is as follows:
C down no_light
TR no_light = -------------------------------
- (2)
C up no_light
where
TRno_light = no-light transmission rate
Cdown, no_light = downstream, no light, culturable bioaerosol concentration, CFU/m3 (CFU/ft3)
Cup, no_light = upstream, no light, culturable bioaerosol concentration, CFU/m3 (CFU/ft3)
To remove this system bias, the single-pass bioaerosol inactivation efficiency shall be cor-
rected by the no-light transmission rate. Thus, the final corrected form of Equation 2 becomes
as follows:
c downstream
UVGI corr (%) = 1 – --------------------------------------------------
- 100% (3)
c upstream TR no_light
Single-pass efficiency shall be estimated for each of the three replicate experiments. Vari-
ability of the efficiency due to plating variability shall be estimated by propagating the stan-
8. REPORTING RESULTS
8.1 Outline. The summary section of the performance report shall include the following infor-
mation:
a. Name and location of the test laboratory
b. Date of the test
c. Test operators’ names
d. UV-C device manufacturer’s name (or name of the marketing organization, if different
from the manufacturer)
e. How the UV-C device was obtained
f. Description of the test UV-C device, including the following:
1. Brand and model number
2. Physical description of construction, including lamps, part number of lamps, number of
lamps, and power supply
3. Photos of device as positioned in the test rig
g. Operation information as stated by the manufacturer
1. Recommended operating conditions for reporting purposes: airflow rate in m/s (fpm),
temperature in degrees Celsius (degrees Fahrenheit), humidity, voltage input, input
power, and static pressure
h. Test data
1. Test air temperature and relative humidity
2. Airflow rate
3. Reflectivity measurements of interior duct wall
4. Lights-on/lights-off test
5. No-device test
6. Type of test aerosol for biological test
7. Calculations
8. Input volts and watts
i. Single-pass bioaerosol inactivation efficiency
j. Optional temperature and velocity curves of irradiance as supplied by the UV device man-
ufacturer
9. NORMATIVE REFERENCES
1. ASHRAE. 2017. ANSI/ASHRAE Standard 52.2, Method of Testing General Ventilation
Air-cleaning Devices for Removal Efficiency by Particle Size. Atlanta: ASHRAE.
2. IESNA. 2000. IESNA Lighting Handbook, 9th ed. M. Rea, ed. New York: Illuminating
Engineering Society of North America.
3. Kujumdzic, E., M. Hernandez, and S.L. Miller. 2007. Ultraviolet germicidal irradiation
inactivation of airborne fungal spores and bacteria in upper-room air and HVAC in-duct
configurations. Journal of Environmental Engineering Science 6:1–9.
4. Hernandez, M., S.L. Miller, D.W. Landfear, and J.M. Macher. 1999. A combined fluoro-
chrome method for quantification of metabolically active and inactive airborne bacteria.
Aerosol Science and Technology 30(2):145–60.
5. Miller-Leiden, S., C. Lobascio, W.W. Nazaroff, and J.M. Macher. 1996. Effectiveness of
in-room air filtration and dilution ventilation for tuberculosis infection control. Journal
of the Air and Waste Management Association 46(9):869–82.
6. VanOsdell, D.W., and K.K. Foarde. 2002. Defining the effectiveness of UV lamps installed
in circulation air ductwork. Report number DOE/OR22674/610-40030-01R. RTI Inter-
national, Research Triangle Park, NC.
7. Xu, P., E. Kujundzic, J. Peccia, M.P. Schafer, G. Moss, M. Hernandez, and S.L. Miller.
2005. Impact of environmental factors on efficacy of upper-room air in inactivating air-
borne mycobacteria. Environmental Science and Technology 39(24):9656–664.
INFORMATIVE APPENDIX A
TEST ORGANISM
This standard is based on two test organisms (Section 6.1.1). Other organisms may also be
chosen and used with the methodology of the test.
Microorganisms vary in both size and shape and should therefore be selected to reflect their
natural diversity. Additionally, because the efficacy of UV-C radiation to inactivate microor-
ganisms is being evaluated, it is necessary to select microorganisms that range from readily
inactivated to more difficult to inactivate. Generally, vegetative bacteria are readily inactivated,
and bacterial spores are activated with more difficulty (Informative Appendix E, Figure E-1).
Inactivated is typically understood to mean that the microorganism does not have the ability to
replicate. The susceptibility of a microorganism to UV-C radiation is defined as the k-value for
a single-pass flow reactor and is expressed as cm2/µW·s. The magnitude of the k-value defines
the susceptibility: large k-values indicate low susceptibility to, and small k-values indicate high
susceptibility to, inactivation by UV-C radiation.
INFORMATIVE APPENDIX B
LIMITATIONS
The results of this test should not be extrapolated to higher or lower air velocities and/or air
temperatures or to larger or smaller duct sizes.
The results of the test do not predict performance over service life. The equipment provided
would be expected to give a potential user some estimate of the service life characteristics of
the device for a specified set of expected operating conditions.
The results only show downstream effects on culturable bioareasols.
ASHRAE does not actually test UV systems or determine their performance, it only pro-
mulgates the test procedure used by manufacturers and independent testing laboratories.
UV device testing in a laboratory is intended to help the user compare the performance of
different types of UV systems. Testing attempts to simulate the performance of UV devices in
real-life operation but cannot duplicate field conditions. Field conditions vary from location to
location. The reporting values obtained in accordance with this standard cannot be used by
themselves to predict the air cleanliness of a specific ventilated space or the service life of
installed UV devices.
Users of the method should have a comprehensive knowledge of microbiology and should
be experienced with standard microbiological methods. A familiarity with the terminology and
operation of airflow systems and particulate aerosols is also helpful.
Furthermore, the user must understand that collection and enumeration of viable bioaero-
sols involves instrumentation and equipment that may not be 100% efficient under all use con-
ditions; this should be considered when interpreting results. The control tests described in
Section 5, and the quality control parameters specified in Sections 4, 5 and 7, are included to
ensure that reliable information is available when interpreting the results and calculating the
inactivation efficiency determined for a device. Devices may vary dramatically, and each may
require unique testing conditions.
Users of the method will need to determine if their particular device requires specialized
testing conditions; however, the general approach described here should be applicable to most
technologies. If the performance of multiple technologies is to be compared, then the test lab
needs to standardize all variables of the test plan.
INFORMATIVE APPENDIX C
SAFETY
The primary safety concern associated with this method is exposing test personnel to aerosol-
ized microorganisms. All microorganisms may be considered opportunistic pathogens,
depending upon the susceptibility and immunological condition of an individual. There are
four biosafety levels (BSLs) for activities with microorganisms, based on the potential risk
posed by the organism and the intended activities in the laboratory. Guidelines for the appro-
priate practices, safety equipment, and facilities are described in Biosafety in Microbiological
and Biomedical Laboratories (BMBL) (CDC 2007). Prior to initiating any tests, a bioaerosol
risk assessment should be performed to establish the BSL needed. BSL-1 safety practices and
controls are appropriate for microorganisms not normally associated with human disease.
BSL-2 is recommended for organisms associated with human disease that pose a moderate
hazard to workers. BSL-3 is applicable to indigenous/exotic agents associated with human dis-
ease and with the potential for aerosol transmission. BSL-4 is needed for dangerous/exotic
agents of a life-threatening nature. BSL-2, BSL-3, and BSL-4 work requires specialized con-
tainment that is not detailed in this test method.
Laboratories preparing to perform bioaerosol aerosol testing should have a bioaerosol
safety plan, and all personnel should be trained in the risks of working with aerosolized micro-
organisms. The BMBL provides general guidelines for developing a bioaerosol safety plan and
provides overall guidance on bioaerosol safety. Test personnel should read and understand this
document prior to using this test method. Institutional biosafety rules should be followed.
In addition to the biosafety issues, other safety issues associated with this method may at
times require safe transport (including lifting) and use of various heavy and awkward equipment.
No personnel should be subject to direct UV exposure, but if exposure is unavoidable, per-
sonnel should wear protective clothing (no exposed skin), protective eyewear, and gloves. Most
eyewear, including prescription glasses, are sufficient to protect eyes from UV, but not all offer
complete coverage; standard issue protective goggles may be the best alternative.
INFORMATIVE APPENDIX D
ENVIRONMENTAL CONSIDERATIONS
The method described herein is a laboratory procedure, and release of microorganisms into the
environment should not be permitted. Engineering controls as described in Biosafety in Micro-
biological and Biomedical Laboratories (BMBL) (CDC 2007), when used on the test systems,
are designed to prevent such a release. However, a risk analysis should be performed to assess
the possibility of an accidental release. If this analysis indicates a high likelihood of such, then
the effect that the microorganisms may have on the environment should be assessed. Many
microorganisms only requiring BSL-1 containment for human health, while not infectious to
humans, may be plant pathogens and may have a detrimental impact on the environment. The
American Type Culture Collection (ATCC), the Centers for Disease Control (CDC), and the
United States Department of Agriculture (USDA) have published information on plant patho-
gens. Issues raised therein should be addressed in laboratory environmental safety plans.
INFORMATIVE APPENDIX E
MICROORGANISM SUSCEPTIBILITY TO UV-C RADIATION
INFORMATIVE APPENDIX F
TECHNICAL ISSUES REGARDING AEROSOL
The use of microorganisms as the challenge aerosol requires that a number of technical issues
be addressed with the generator. These include the following:
a. Measuring the survivability and culturability of the organisms through the aerosol genera-
tion and collection process
b. Determining whether the test organisms are being aerosolized as singlets with a narrow size
distribution when appropriate
c. Generating the bioaerosol challenge in sufficient concentration to maintain the sampling
duration within the sample time limits of the bioaerosol sampler and to enable detection
upon extraction and assay
INFORMATIVE APPENDIX G
DOSAGE CALCULATION
The term Nt /N0 from Equation G-1 is the survival rate of the test microorganism after expo-
sure to UV. Due to the complexity of bioaerosol testing, an accurate determination of the air-
borne survival rate requires a series of tests and the determination of the corrected survival
rate. Nt /No is the Survival Ratecorrected, which shall be calculated as described below.
N t N 0 = exp – k Dose (G-1)
where
Nt = number of microorganisms at any time t
N0 = number of microorganisms at start before exposure begins
k = a microorganism-dependent rate constant, cm2/µW·s
INFORMATIVE APPENDIX H
INFORMATIVE REFERENCES
Abramowitz, M., and I.A. Stegun. 1972. Handbook of Mathematical Functions with Formulas,
Graphs and Mathematical Tables, 9th printing with corrections. New York: Wiley.
CDC. 2007. Biosafety in Microbiological and Biomedical Laboratories, 5th edition. Atlanta:
Centers for Disease Control.
Grinshpun, S., S. Sivasubramani, and T. Reponen. 2003. Aerosolization of Aspergillus versi-
color spores from different building materials. In Proceedings of the 22nd Annual American
Aerosol Association Research Conference, pp. 82, Anaheim, California, 20–24 October
2003. American Association for Aerosol Research, Mt. Laurel NJ.
Kujumdzic, E., M. Hernandez, and S.L. Miller. 2007. Ultraviolet germicidal irradiation inacti-
vation of airborne fungal spores and bacteria in upper-room air and HVAC in-duct configu-
rations. Journal of Environmental Engineering Science 6:1–9.
VanOsdell, D.W., and K.K. Foarde. 2002. Defining the effectiveness of UV lamps installed in
circulation air ductwork. Report number DOE/OR22674/610-40030-01R. RTI Interna-
tional, Research Triangle Park, NC.
Wayne, L.G., and G.P. Kubica. 1986. Genus mycobacterium. In Bergy’s Manual for Systematic
Bacteriology, pp. 1435–457, Eds. N.R. Krieg and J.G. Holt. Baltimore, MD: Williams and
Wilkins.
Xu, P., J. Peccia, P. Fabian, J.W. Martyny, K.P. Fennelly, M. Hernandez, and S.L. Miller. 2003.
Efficacy of ultraviolet germicidal irradiation of upper-room air in inactivating airborne bacte-
rial spores and mycobacteria in full-scale studies. Atmospheric Environment 37(3):405–19.
Xu, P., E. Kujundzic, J. Peccia, M.P. Schafer, G. Moss, M. Hernandez, and S.L. Miller. 2005.
Impact of environmental factors on efficacy of upper-room air in inactivating airborne
mycobacteria. Environmental Science and Technology 39(24):9656–664.
(This appendix is not part of this standard. It is merely informative and does not contain requirements necessary for conformance to
the standard. It has not been processed according to the ANSI requirements for a standard and may contain material that has not
been subject to public review or a consensus process. Unresolved objectors on informative material are not offered the right to
appeal at ASHRAE or ANSI.)
INFORMATIVE APPENDIX I
ADDENDA DESCRIPTION AND INFORMATION
ANSI/ASHRAE Standard 185.1-2020 incorporates ANSI/ASHRAE Standard 185.1-2015 and Addenda a, b, and c to ANSI/ASHRAE Stan-
dard 185.1-2015. Table I-1 lists each addendum and describes the way in which the standard is affected by the changes. It also lists the
ASHRAE and ANSI approval date for each addendum.
a 6.1.2 The liquid that is used in generating a bioaerosol will provide different levels of protection for the microorganism. For July 25, 2019
the tests to be repeatable, the generation of the bioaerosol must result in equal levels of protection. Addendum a adds
the requirement for the liquid to be the same.
b 6.1.2; 7, 7.1, 7.2 (removed) The use of the Poisson distribution is not appropriate for this type of biological data. The degree of correction is based June 30, 2020
on total counts, so a test with thousands of counts receives a tighter confidence interval than one with hundreds. This
could result in very different reported efficiencies between tests. Also, because counting plates for microorganisms
requires that colonies be separate, there is an upper limit on raw counts per plate. To obtain high counts, a great number
of plates must be run. In addition, the test lab must estimate the actual concentrations to determine how long to sample
or how much to plate. If the level is too high, the plates are overgrown and not usable; if too low, the counts will be low.
ANSI/ASHRAE Standard 185.1-2020
Given that the efficiency of the devices isn’t known ahead of time, in order to obtain high counts repeated tests must be
run. To achieve tight confidence intervals with these calculations would require great expense.
In addition, this method of calculation does not address the issue of variability at the test lab, because the total counts
are used. It seems preferable to report the counts, the average, and the standard deviation to give an average efficiency
and a measure of the sample count variability.
c 4.1.2; 5; Table 1 Addendum c serves two purposes. The first is to correct the airflow rate to 2000 cfm. The second is to provide guidance January 31, 2020
in quality assurance testing to ensure that test labs are performing the tests in the same way.
* These descriptions may not be complete and are provided for information only.
NOTE
Approved addenda, errata, or interpretations for this standard can be downloaded free of charge from the
ASHRAE website at www.ashrae.org/technology.
© ASHRAE. Provided to the public as part of ASHRAE'S COVID-19 response . Per international copyright law,
additional reproduction, distribution, or transmission in either print or digital form is not permitted without ASHRAE's prior written permission.
POLICY STATEMENT DEFINING ASHRAE’S CONCERN
FOR THE ENVIRONMENTAL IMPACT OF ITS ACTIVITIES
ASHRAE is concerned with the impact of its members’ activities on both the indoor and outdoor environment.
ASHRAE’s members will strive to minimize any possible deleterious effect on the indoor and outdoor environment of
the systems and components in their responsibility while maximizing the beneficial effects these systems provide,
consistent with accepted Standards and the practical state of the art.
ASHRAE’s short-range goal is to ensure that the systems and components within its scope do not impact the
indoor and outdoor environment to a greater extent than specified by the Standards and Guidelines as established by
itself and other responsible bodies.
As an ongoing goal, ASHRAE will, through its Standards Committee and extensive Technical Committee structure,
continue to generate up-to-date Standards and Guidelines where appropriate and adopt, recommend, and promote
those new and revised Standards developed by other responsible organizations.
Through its Handbook, appropriate chapters will contain up-to-date Standards and design considerations as the
material is systematically revised.
ASHRAE will take the lead with respect to dissemination of environmental information of its primary interest and
will seek out and disseminate information from other responsible organizations that is pertinent, as guides to updating
Standards and Guidelines.
The effects of the design and selection of equipment and systems will be considered within the scope of the
system’s intended use and expected misuse. The disposal of hazardous materials, if any, will also be considered.
ASHRAE’s primary concern for environmental impact will be at the site where equipment within ASHRAE’s scope
operates. However, energy source selection and the possible environmental impact due to the energy source and
energy transportation will be considered where possible. Recommendations concerning energy source selection
should be made by its members.
© ASHRAE. Provided to the public as part of ASHRAE'S COVID-19 response . Per international copyright law,
additional reproduction, distribution, or transmission in either print or digital form is not permitted without ASHRAE's prior written permission.
About ASHRAE
Founded in 1894, ASHRAE is a global professional society committed to serve humanity by advancing the arts and
sciences of heating, ventilation, air conditioning, refrigeration, and their allied fields.
As an industry leader in research, standards writing, publishing, certification, and continuing education, ASHRAE
and its members are dedicated to promoting a healthy and sustainable built environment for all, through strategic
partnerships with organizations in the HVAC&R community and across related industries.
To stay current with this and other ASHRAE Standards and Guidelines, visit www.ashrae.org/standards, and
connect on LinkedIn, Facebook, Twitter, and YouTube.
To ensure that you have all of the approved addenda, errata, and interpretations for this
Standard, visit www.ashrae.org/standards to download them free of charge.
Addenda, errata, and interpretations for ASHRAE Standards and Guidelines are no
longer distributed with copies of the Standards and Guidelines. ASHRAE provides
these addenda, errata, and interpretations only in electronic form to promote
more sustainable use of resources.